Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
FastMed Introduces Online Weight Loss Program with Legitimate GLP-1 Medication - Featured image
Health

FastMed Introduces Online Weight Loss Program with Legitimate GLP-1 Medication

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·December 19, 2025·2 min read

On this page

  • FastMed Introduces Online Weight Loss Program with Legitimate GLP-1 Medication
  • Weight Management: A Critical Health Concern
  • Three-Step Safety Protocol
  • Technology Enhances Healthcare Accessibility

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

In response to the increasing demand for GLP-1 weight-management solutions and the risks associated with unregulated online sales, FastMed has launched a program providing a secure and compliant channel for individuals seeking weight management assistance. The platform emphasizes the importance of medical supervision when using prescription weight-loss medications.

Share

On this page

  • FastMed Introduces Online Weight Loss Program with Legitimate GLP-1 Medication
  • Weight Management: A Critical Health Concern
  • Three-Step Safety Protocol
  • Technology Enhances Healthcare Accessibility

FastMed Introduces Online Weight Loss Program with Legitimate GLP-1 Medication

Amid a global increase in demand for the weight-management ingredient GLP-1, the Hong Kong market has faced issues such as unauthorized sales and online purchases without a doctor's prescription. As a result, FastMed, a local telemedicine and dispensing platform, has launched a genuine GLP-1 product, delivering a safe and compliant online avenue for those seeking assistance with weight management.

Weight Management: A Critical Health Concern

The World Health Organization recognizes obesity as a chronic disease. While GLP-1-based medications are in high demand, FastMed highlights that they are prescription drugs. Serious side effects may result from inappropriate use.

The platform has noticed numerous unofficial channels selling weight-loss injections locally. Public users who use these without proper medical evaluation may experience not only limited efficacy but also potential health risks. FastMed aims to offer the public access to appropriate medical advice through regulated online channels and reduce the circulation of non-compliant or counterfeit drugs, committing to providing medical services, not just medication sales. Health tracking apps like Shotlee can help monitor progress and potential side effects during weight management programs.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Three-Step Safety Protocol

The FastMed weight management program adheres to a strict medical process, setting it apart from typical e-commerce platforms:

  • Consultation: Initial assessment by a registered doctor.
  • Prescription: If deemed suitable, a prescription for GLP-1 medication is issued.
  • Delivery: Medication is dispensed and delivered through a regulated channel.

Technology Enhances Healthcare Accessibility

Through FastMed's platform, users gain access to medical services comparable to in-clinic standards without requiring in-person visits. The process is designed to be highly private, enabling individuals to manage their health safely and conveniently under medical supervision.

The medications mentioned are prescription-only. Effectiveness and side effects can vary. A clinical assessment by a registered doctor is necessary to determine suitability. Do not purchase or use without medical supervision.

Source Information

Originally published by Media Outreach.Read the original article →

Read next

Keep exploring

Same topic: obesity

All obesity articles →
Ozempic and the Shift: Real Data on America's Obesity Rates
Health & Wellness

Ozempic and the Shift: Real Data on America's Obesity Rates

New data from EPIC Research highlights a correlation between rising GLP-1 prescriptions and a modest decline in US obesity rates, offering hope amidst ongoing challenges.

7 min read
Retatrutide: A New Era in Weight Loss Drugs vs. Ozempic
Weight Management

Retatrutide: A New Era in Weight Loss Drugs vs. Ozempic

Eli Lilly's experimental drug retatrutide has demonstrated unprecedented weight loss results in a pivotal trial. This article delves into its mechanisms, efficacy, safety, and how it stacks up against current leading weight loss medications like Ozempic and Wegovy.

6 min read
New Procedure May Combat Weight Regain After GLP-1s
Weight Management

New Procedure May Combat Weight Regain After GLP-1s

Losing weight with GLP-1 medications like semaglutide and tirzepatide is a significant achievement, but maintaining that loss after stopping treatment presents a major challenge. A new experimental procedure, duodenal mucosal resurfacing (DMR), is showing remarkable potential in helping individuals keep the pounds off.

7 min read

More in Health

Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds
Health & Wellness

Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds

A comprehensive guide to GLP-1 receptor agonists, understanding efficacy, managing side effects, and navigating the future of obesity treatment.

7 min read
Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation
Health & Wellness

Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation

The GLP-1 revolution is just the beginning. This article delves into the cutting-edge advancements poised to reshape the future of weight loss and metabolic health, offering insights for patients and observers alike.

7 min read
Beyond Weight Loss: The Next Wave of GLP-1 Drugs
Health & Wellness

Beyond Weight Loss: The Next Wave of GLP-1 Drugs

The revolutionary GLP-1 medications have transformed weight management, but the journey of innovation continues. Discover how upcoming drugs aim to enhance patient experience and outcomes.

7 min read
Share this article
  1. Home
  2. Blog
  3. FastMed Introduces Online Weight Loss Program with Legitimate GLP-1 Medication
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community